Memorial Sloan Kettering Cancer Center — Q3 2023 13F-HR

← Memorial Sloan Kettering Cancer Center

Q3 2023 · 13F-HR

Memorial Sloan Kettering Cancer Centerholdings as filed

Filed 2023-11-14 · accession 0000921895-23-002627

$24.6M

Reported value

Positions

2023-09-30

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
92189F106	GDX	VANECK ETF TRUST	$19.9M	80.9%	738,500	Common	SOLE
68622P109	ORIC	ORIC PHARMACEUTICALS INC	$3.6M	14.8%	602,272	Common	SOLE
984241109	YMABUSD	Y-MABS THERAPEUTICS INC	$1.0M	4.24%	191,176	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.